Your A-Z of episodes

Did you know there’s even more we can do to promote your episode? Find out more…

  • Episode 197

    Baking success to IQVIA exit

    Tessa Pugh

    / PharmaReview

    Tessa Pugh, ex-CEO at PharmaReview, shares her journey from co-founder to CEO, driving growth and leading a PE-backed exit to IQVIA.

  • Episode 196

    The biotech-MedTech CEO tackling obesity

    Camila Easter

    / Oxford Medical Products (OMP)

    Camila Easter, CEO at Oxford Medical Products, shares her journey from the veterinary field to making waves in the GLP-1 space.

  • Episode 195

    Delhi boy, done good

    Akshay Peer

    / Trakcel

    Akshay Peer, co-founder and SVP at TrakCel, joins the podcast to share why streamlining software is vital for the CGT space.

  • Episode 194

    Meet the Top Gun CDMO Maverick

    John Fowler

    / Pii (Pharmaceutics International, Inc.)

    John Fowler, CEO at Pii, joins the podcast to share insights on the skills needed to lead a successful CDMO in today’s challenging market.

  • Episode 193

    Pfizer’s retired manufacturing veteran

    Peter Stevenson

    / Independent Director and Pharma industry veteran

    Pharma industry veteran Peter Stevenson joins the podcast to share insights from his experience leading Pfizer’s CDMO, Pfizer CentreOne.

  • Episode 192

    Tasty Topics: Navigating Novo Nordisk’s Acquisition of Catalent

    Dirk Lange, Brett Alderson, John Cameron & Janet Hoogstraate

    / Pyramid Labs, NovaCina, Corden Pharma & NorthX Biologics

    Hear sector experts discuss the potential impacts of Novo’s acquisition of Catalent and maximizing GLP-1 manufacturing capacity.

  • Episode 191

    Reimagining drug development

    Jen Nwankwo

    / 1910 Genetics

    Jen Nwankwo, Founder and CEO of 1910 Genetics, recently joined the podcast to discuss how 1910 is reshaping the industry and drug discovery.

  • Episode 190

    A lifetime of drug hunting

    Karen Lackey

    / X-Chem

    Karen Lackey, CEO at X-Chem recently discussed why she moved away from Big Pharma after 30 years to move to a global CRO.

  • Episode 189

    The pink-haired CEO

    Emma Banks

    / ramarketing

    Emma Banks, CEO at ramarketing, joined the podcast and spoke on how, despite market headwinds, the pharma services sector is looking up.

  • Episode 188

    The Harvard spin-out disrupting drug discovery

    Rani Powers

    / Pluto Bio

    Rani Powers, Founder & CEO of Pluto Bio, shares how her passion for coding and biology led to Pluto, a platform accelerating drug discovery.

  • Load more